Formula Shortage Reporting Act of 2022
Official title: To authorize the Food and Drug Administration to require manufacturers of infant formula to warn about a discontinuance or interruption in the production of infant formula, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the House Committee on Energy and Commerce.
Formula Shortage Reporting Act of 2022
This bill requires manufacturers of infant formula to notify the Food and Drug Administration (FDA) at least 72 hours in advance of a manufacturing interruption or product discontinuance that is expected to meaningfully disrupt the product's supply. The FDA must post such information on its website and notify health care providers.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 8038: Formula Shortage Reporting Act of 2022. 117th Congress. Open America. https://openamerica.io/bill/117-HR-8038/
"H.R. 8038: Formula Shortage Reporting Act of 2022." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-8038/.
H.R. 8038, 117th Cong. (2026), https://openamerica.io/bill/117-HR-8038/.
[H.R. 8038: Formula Shortage Reporting Act of 2022](https://openamerica.io/bill/117-HR-8038/)